Bionova Scientific, U.S. biologics CDMO of the Asahi Kasei Group, to establish a facility in Texas and launch plasmid DNA business
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240603320522/en/
![Shown is the Research Forest in The Woodlands, Texas, the planned future site of Bionova’s pDNA facility. (Photo: Business Wire)](https://mms.businesswire.com/media/20240603320522/en/2146609/4/2024_06_BionoveExpansion_AKC.jpg)
Shown is the
The bioprocess business of
As a biologics CDMO that provides process development and manufacturing services to pharmaceutical companies, Bionova is well regarded for its capability of process development for complex next-generation antibody-based drugs whose manufacture tends to be difficult. To broaden its services portfolio, Bionova looked for opportunities to enter new therapeutic modalities such as cell and gene therapies, which are expected to grow rapidly.
Plasmids are DNA molecules that exist in the cells of microorganisms such as E. coli. They are increasingly used as important starting material in fields of biotechnology such as cell and gene therapies, mRNA vaccines, and antibody drugs. The global plasmid manufacturing market is expected to grow at double-digit rates over the next several years due to the rapid growth of new modalities such as cell and gene therapies. Bionova has decided to contribute to accelerating the growth of such new modalities by leveraging its expertise of manufacturing process development, GMP manufacturing know-how, flexible customer support, and industry network in the targeted new modalities.
For process development and GMP manufacturing of plasmids, Bionova will establish a new facility in
Please refer to the press release dated
“Asahi Kasei Medical to acquire Bionova Scientific,
https://www.asahi-kasei.com/news/2022/e220419.html
Please refer to the press release dated
“Bionova Scientific,
https://www.asahi-kasei.com/news/2022/e230202.html
View source version on businesswire.com: https://www.businesswire.com/news/home/20240603320522/en/
christian.okeefe@ak-america.com
sebastian.schmidt@asahi-kasei.eu
Source: